CNS Vital Signs provides clinicians and researchers with leading edge neurocognitive and behavioral health assessment technologies that efficiently collects valid and reliable brain & behavioral clinical endpoints for a more objective view of a patient’s functional status, disease progression, and outcomes.
Attention‐deficit/hyperactivity disorder (ADHD) is a common neurobehavioral condition that impairs functioning throughout childhood, adolescence, and adulthood. Evidence‐based guidelines for the treatment of ADHD recommend recognizing ADHD as a chronic condition across the lifespan.
The CNS Vital Signs Assessment platform supports a lifespan chronic care model and helps enable productive interactions between the family, teachers, and a specialist practice team. Key parent and youth screening tools, parent‐teacherphysician assessment (rating scales), and neurocognitive testing assessments can be used to efficiently evaluate and manage AD/HD, medication titration and ongoing monitoring.
Barriers in primary care settings can impede the delivery of high‐quality AD/HD care and a collaborative (specialist), systems‐based approach can help support the current guidelines and advance AD/HD care.